PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Diabetes drugs taken by over 15 million Americans raises risk of bladder cancer

2012-08-13
(Press-News.org) PHILADELPHIA -- A popular class of diabetes drugs increases patients' risk of bladder cancer, according to a new study published online this month in the Journal of the National Cancer Institute. Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking thiazolidinedione (TZDs) drugs – which account for up to 20 percent of the drugs prescribed to diabetics in the United States -- are two to three times more likely to develop bladder cancer than those who took a sulfonylurea drug, another common class of medications for diabetes.

The authors say the findings are especially important since diabetic patients are known to already be at a slightly increased risk of this type of cancer as compared to the generation population, in which about 30 in 100,000 people develop bladder cancer. Among diabetes patients overall, the incidence of this cancer is typically about 40 out of 100,000.

The authors of the new study analyzed 60,000 Type 2 diabetes patients from the Health Improvement Network (THIN) database in the United Kingdom. They found that patients treated with the TZD drugs pioglitazone (Actos) or rosiglitzaone (Avandia) for five or more years had a two-to-three-fold increase in risk of developing bladder cancer when compared to those who took sulfonylurea drugs. Among patients taking TZDs for that length of time, the team's analysis indicates that 170 patients per 100,000 would be expected to develop the disease. About 60 in 100,000 of those who take sulfonylurea drugs – such as glipizide (Glucotrol) -- would be expected to develop bladder cancer.

"Diabetes is one the most common chronic diseases worldwide, affecting 285 million people. There are many factors clinicians must weigh in deciding which drug to use to control a patient's diabetes, and these new data provide important information to include in that decision-making process," said the study's lead author, Ronac Mamtani, MD, an instructor in the division of Hematology-Oncology in Penn's Abramson Cancer Center. "Our study shows that doctors who care for patients with diabetes should be very aware of any bladder-related symptoms patients might be having, like blood in the urine, and take steps to further evaluate those issues."

Though most patients in the United States no longer take Avandia since it was linked to severe cardiovascular problems, Actos is the ninth most commonly prescribed drug in the nation, accounting for some 15 million prescriptions each year. The drug is a common choice when Type 2 diabetes patients' illnesses can no longer be controlled with the first-line diabetes drug Metformin.

Based on previous data examining safety risks among patients taking Actos, the FDA has already warned that it may be associated with a risk of bladder cancer, and France and Germany have removed the drug from their markets. The new findings add to mounting evidence against the entire class of TZDs, as one of the first studies examining this type of risk among people taking both types of TZDs and among those taking sulfonylurea drugs.

"The risk does seem to be common among both drugs in the TZD class, and the fact that we have compared bladder cancer risk among patients taking each of those drugs provides essential information, because a safety warning on a drug is only useful to a doctor when they have knowledge of the same risks for an alternative drug," Mamtani says. "We believe our study will help doctors and their patients weigh the potential benefits and risks when selecting between different diabetes medication."

###

The study was funded by the National Institutes of Health (T32-CA009679-20, UL1-RR024134, and K24-DK078228).

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital — the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.

END



ELSE PRESS RELEASES FROM THIS DATE:

Mount Sinai researchers identify new drug target for schizophrenia

2012-08-13
Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave the way for a new class of drugs to help treat this devastating mental illness, which impacts one percent of the world's population, 30 percent of whom do not respond to currently available treatments. A team of researchers at Mount Sinai School of Medicine set out to discover what epigenetic factors, or external factors that influence gene expression, are involved in ...

Existing drugs offer new treatment options for high-risk childhood leukemia subtype

2012-08-13
Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies. The study focused on a subtype of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-like ALL (Ph-like ALL). This subgroup accounts for as much as 15 percent of childhood ALL that is associated with a high risk of relapse and a poor outcome. The genetic changes driving the disease were previously unknown for about half of all patients with Ph-like ALL. The work identified ...

Are methane hydrates dissolving?

2012-08-13
The average temperatures of the atmosphere are rising; the average temperatures of the oceans, too. Not only living organisms react sensititvely to these changes. The transitional zones between shallow shelf seas and the deep sea at continental slopes store a huge amount of methane hydrates in the sea bed. These specific, ice-like compounds only forms at low temperatures and under high pressure. When the water temperature directly above the sea bed rises, some of the methane hydrates could dissolve and release the previously bound methane. "This scenario incorporates two ...

Scientists use light to 'tag and track' genetic processes

2012-08-13
In a new study, UT Dallas researchers outline how they used fluorescent molecules to "tag" DNA and monitor a process called DNA looping, a natural biological mechanism involved in rearranging genetic material in some types of cells. The UT Dallas "tag and track" method not only sheds light on how DNA loops form, but also might be adapted to screen drugs for effectiveness against certain viruses that shuffle genetic material, such as HIV. Until now, scientists primarily had "snapshots" of the initial and final stages of DNA loop formation, with only limited information ...

Consumers perceive risk when 'price' means more than money

Consumers perceive risk when price means more than money
2012-08-13
When companies combine different pricing structures – such as asking for effort or information in combination with or instead of money – consumers perceive a greater risk in the decision to buy. That's according to University of Cincinnati research to be presented at the Aug. 15-17 Behavioral Pricing Conference in Detroit, Mich., by doctoral marketing student John Dinsmore. His paper is titled "Mental Accounting, General Evaluability Theory and the Framing Losses Posed by Partitioned Monetary and Nonmonetary Prices." According to Dinsmore, shoppers routinely arrive ...

Butter flavoring in microwave popcorn, thought safe for food industry workers, is respiratory hazard

2012-08-13
Philadelphia, PA, August 13, 2012 – The ingredient 2,3-pentanedione (PD), used to impart the flavor and aroma of butter in microwave popcorn, is a respiratory hazard that can also alter gene expression in the brain of rats. Manufacturers started using PD when another butter flavoring, diacetyl, was found to cause bronchiolitis obliterans, a life-threatening and nonreversible lung disease in workers who inhaled the substance. New research on PD with implications for "popcorn workers' lung" is published in The American Journal of Pathology and indicates that acute PD exposure ...

Optics and photonics research priorities, grand challenges presented in new report

2012-08-13
WASHINGTON — A new report from the National Research Council identifies research priorities and grand challenges to fill gaps in optics and photonics, a field that has the potential to advance the economy of the United States and provide visionary directions for future technology applications. The report recommends that the federal government develop a "National Photonics Initiative" to bring together academia, industry, and government to steer federal research and development funding and activities. "Much is unknown when pursuing basic optical science and its transition ...

Researchers identify key culprit causing muscle atrophy

Researchers identify key culprit causing muscle atrophy
2012-08-13
Whether you're old, have been ill, or suffered an injury, you've watched gloomily as your muscles have atrophied. The deterioration of muscle—even slight or gradual—is about as common to the human condition as breathing. Yet despite its everyday nature, scientists know little about what causes skeletal muscles to atrophy. They know proteins are responsible, but there are thousands of possible suspects, and parsing the key actors from the poseurs is tricky. In a new paper, researchers from the University of Iowa report major progress. The team has identified a single ...

New key element discovered in pathogenesis of Burkitt lymphoma

2012-08-13
Burkitt lymphoma is a malignant, fast-growing tumor that originates from a subtype of white blood cells called B lymphocytes of the immune system and often affects internal organs and the central nervous system. Now Dr. Sandrine Sander and Professor Klaus Rajewsky of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch have identified a key element that transforms the immune cells into malignant lymphoma cells. They developed a mouse model that closely resembles Burkitt lymphoma in humans and that may help to test new treatment strategies (Cancer Cell)*. Burkitt ...

Gene discovery could improve treatment for acute myeloid leukemia

2012-08-13
August 13, 2012 ─ (BRONX, NY) ─ Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could mean that people with acute myeloid leukemia (AML), a rare and usually fatal cancer, are a step closer to new treatment options. Their study results were published online today in Cancer Cell. "We have discovered that a gene called HLX is expressed at abnormally high levels in leukemia stem cells in a mouse model of AML," said Ulrich Steidl, M.D., Ph.D., assistant professor of cell biology and of ...

LAST 30 PRESS RELEASES:

Disparities in treatment and referral after an opioid overdose among emergency department patients

Was Mars doomed to be a desert? Study proposes new explanation

Study highlights major hurdles for multinational clinical trials in Europe

Chemistry breakthrough has potential to make more effective cancer drugs with less harmful side effects

Researchers identify new protein target to control chronic inflammation

Increasing contingency management incentives will help more patients recover from addiction

Changes in the blood could protect against Alzheimer’s disease

New tool allows researchers to track assembly of cells’ protein-making machines

New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers 

AI that thinks like us – and could help explain how we think

The imitation game – why are some species better at fooling predators than others?

Gas leakage triggers wound healing in plants

Forging a novel therapeutic path for patients with Rett Syndrome using AI

Global drought hotspots report catalogs severe suffering, economic damage in 2023-2025

Study: To battle tip fatigue, businesses should make their service efforts visible

This spongy material and the sun’s power remove salt from seawater

Nearly 1 in 6 older adults take aspirin despite no history of heart disease

ACMG takes action to address national gap in newborn screening leadership

Stopping pancreatic cancer spread using benzaldehyde

Pusan National University study reveals engineered bacterial vesicles to combat antimicrobial resistance

Africa needs more large firms, not more entrepreneurs, for economic growth

Clues in the claws: finger length may reveal sexual preferences in rats

World-unique method enables simulation of error-correctable quantum computers

Scientists uncover immune cells that help prostate cancer resist treatment — and reveal a way to stop them

Cellulose instead of crude oil: team with participation of Graz University of Technology develops sustainable foams

New fossils from Earth’s most famous extinction show climate tipping point was crossed

AI predicts patients likely to die of sudden cardiac arrest

Double detonation: New image shows remains of star destroyed by pair of explosions

Gene therapy restored hearing in deaf patients

Survey finds Trump losing favor, Newsom gaining

[Press-News.org] Diabetes drugs taken by over 15 million Americans raises risk of bladder cancer